Evidence mapPaperPMID 39082939Full record

ArticleeLife2024

A kidney-hypothalamus axis promotes compensatory glucose production in response to glycosuria.

Tumininu S Faniyan, Xinyi Zhang, Donald A Morgan, Jorge Robles, Siresha Bathina, Paul S Brookes, Kamal Rahmouni, Rachel J Perry, Kavaljit H Chhabra

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Thiazolidinedione enhances the efficacy of anti-PD-1 monoclonal antibody in murine melanoma.American journal of physiology. Endocrinology and metabolism · 2024
    Article
  4. Metabolic underpinnings of cancer-related fatigue.American journal of physiology. Endocrinology and metabolism · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Tumininu S FaniyanDepartment of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Rochester Medical Center, Rochester, United States.
Xinyi ZhangDepartment of Cellular and Molecular Physiology, Yale University, New Haven, United States.
Donald A MorganDepartment of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, United States.
Jorge RoblesDepartment of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Rochester Medical Center, Rochester, United States.
Siresha BathinaDepartment of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Rochester Medical Center, Rochester, United States.
Paul S BrookesDepartment of Anesthesiology, University of Rochester Medical Center, Rochester, United States.ORCID https://orcid.org/0000-0002-8639-8413
Kamal RahmouniDepartment of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, United States.
Rachel J PerryDepartment of Cellular and Molecular Physiology, Yale University, New Haven, United States.ORCID https://orcid.org/0000-0003-0748-8064
Kavaljit H ChhabraDepartment of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Rochester Medical Center, Rochester, United States.ORCID https://orcid.org/0000-0001-6378-3645

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
Mitochondria &NO in Cardiac Ischemia-ReperfusionR01HL071158 · UNIVERSITY OF ROCHESTER · 2003 to 2025
$1.4M
Defining the Role of Renal Gluconeogenesis in Renal Cell CarcinomaR37CA258261 · NCI · YALE UNIVERSITY · 2023 to 2025
$1.3M
Role of FGF21 Action in Hypothalamic Neurons in Obesity-Associated HypertensionR01HL162773 · NHLBI · UNIVERSITY OF IOWA · 2024 to 2025
$1.2M
Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal GlandsR01DK124619 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$337k
Neuronal Mechanisms of Obesity-Induced HypertensionI01BX004249 · VA · IOWA CITY VA MEDICAL CENTER · 2024 to 2025
BLRD Research Career Scientist Award ApplicationIK6BX006040 · IOWA CITY VA MEDICAL CENTER · 2025 to 2025
BLRD VA I01 BX004249BLRD VA IK6 BX006040NCATS NIH HHS UL1 TR001863NCI NIH HHS R37 CA258261NHLBI NIH HHS R01 HL071158NHLBI NIH HHS R01 HL162773NIDDK NIH HHS R01 DK124619NIH HHS CA258261NIH HHS DK124619NIH HHS HL071158
6 · The paper itself

Abstract

The kidneys facilitate energy conservation through reabsorption of nutrients including glucose. Almost all the filtered blood glucose is reabsorbed by the kidneys. Loss of glucose in urine (glycosuria) is offset by an increase in endogenous glucose production to maintain normal energy supply in the body. How the body senses this glucose loss and consequently enhances glucose production is unclear. Using renal

Indexed as

GlucoseGlucose Transporter Type 2GlycosuriaHypothalamusKidneyMice, KnockoutAnimalsHypothalamo-Hypophyseal SystemMaleMicePituitary-Adrenal SystemGlucoseGlucose Transporter Type 2Slc2a2 protein, mousediabetesglucoseGLUT2glycosuriahypothalamuskidneysmedicinemouse

Identifiers

PMID39082939
PMCPMC11290820

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.